Able Sciences

Reimagining cell engineering for the next generation disease fighting cells

Princeton, United States · Founded 2023 · $7.5M raised

Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$7.5M
Last Round
$7.5M SeedJan 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

Able Sciences is a biotechnology company developing off-the-shelf, allogeneic cell therapies built on an RNA-based cell-engineering platform. Its lead programs use natural killer (NK) cells engineered to express multiple kill signals in a single step, creating a multivalent, combination-style approach aimed at solid tumors and autoimmune disorders. Backed by SOSV's IndieBio accelerator, the seed-stage company was co-founded in 2023 by CEO Jolly Mazumdar and CSO Thimmaiah Chendrimada.

Summary

Able Sciences is a Biotech company based in Princeton, United States, founded in 2023. It has raised $7.5M in total across 1 round, most recently a $7.5M Seed round in Jan 2026. Investors include SOSV and IndieBio.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundJan 2026
$7.5M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Able Sciences on Indexed.vc
<a href="https://indexed.vc/companies/able-sciences"><img src="https://indexed.vc/api/badge/company/able-sciences" alt="Able Sciences on Indexed.vc" width="260" height="76" /></a>